Saturday, July 11, 2026

pharma · Systemic Lupus Erythematosus

Santhera Pharmaceuticals Holding

Santhera Pharmaceuticals Holding trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Pratteln, CH HQ
2004 Founded
115 Employees
EMA registrant Type
Company details
Status
Public
HQ
Pratteln, CH
Founded
2004
Employees
115
Programs
2
Drugs
1
Patents
0
Intelligence · Clinical Trials

Santhera Pharmaceuticals Holding clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Santhera Pharmaceuticals Holding programs — each row shows trial ID, program name, phase, status, and indication.

Santhera Pharmaceuticals Holding trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Santhera Pharmaceuticals Holding.

  1. blisibimod — Phase 3

    Clinical update
  2. A-623 — Phase 2

    Clinical update

Trial registry

2 studies